Little Green Pharma (ASX:LGP) - CEO Fleta Solomon
CEO Fleta Solomon
Source: Little Green Pharma
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Little Green Pharma (LGP) signs a deal with Frankfurt licenced pharmaceutical wholesaler Ilios Santé for the supply of medicinal cannabis products into Germany
  • Under the agreement, Ilios Santé must purchase minimum orders of a high-THC white-label medicinal cannabis flower product being developed by LGP
  • The contract will last for two years and will have a minimum value of $2 million
  • The company believes the agreement shows its continued success of the extensive genetics program which has resulted in “a world-class” bank of cannabis cultivars
  • Shares in Little Green Pharma close in the day in the grey, trading at 32 cents

Little Green Pharma (LGP) has signed a deal with Frankfurt licenced pharmaceutical wholesaler Ilios Santé for the supply of medicinal cannabis products into Germany.

Under the agreement, Ilios Santé must purchase minimum orders of 20 kilograms per shipment of a high-THC white-label medicinal cannabis flower product being developed by THC.

The 20-kilogram purchase will take place after the first six months, with a projected 80 per cent of minimum quantities falling in the second year.

The contract will last for two years and will have a minimum value of $2 million.

Commenting on the agreement, Little Green Pharma CEO Fleta Solomon said the partnership strengthens the company’s share of the medicinal cannabis product market in Germany as a start.

“[This partnership also] strategically partners us with The Bloomwell Group, a European leader in medical cannabis groups operating along the entire value chain,” she said.

“We look forward to collaborating with Ilios Santé to help service our rapidly growing number of medicinal cannabis patients in Germany.”

The company believes the agreement shows its continued success of the extensive genetics program which has resulted in “a world-class” bank of cannabis cultivars.

Further, the agreement joins Little Green Pharma’s portfolio of rapidly expanding suite of high-value supply agreements in Europe and consolidates its “growing industry reputation” as one of the world’s leading pure-play medicinal cannabis suppliers.

Shares in Little Green Pharma closed in the grey, trading at 32 cents.

LGP by the numbers
More From The Market Herald
Seven West Media (ASX:SWM) - Managing Director, James Warburton.

" Seven West Media (ASX:SWM) reports strongest full-year performance in over a decade

Seven West Media (ASX:SWM) has reported its strongest financial performance in over a decade as net…

" Gascoyne Resources (ASX:GCY) delivers new record intercept at Dalgaranga, WA

Gascoyne Resources (ASX:GCY) delivers a new record intercept at its Dalgaranga gold project in Western Australia.

" Red Mountain Mining (ASX:RMX) completes RC drilling at Mt Mansbridge

Red Mountain Mining (ASX:RMX) has completed reverse circulation drilling at its flagship Mt Mansbridge project in…
The Market Herald Video

" Winsome Resources (ASX:WR1) discovers pegmatite outcrop at Adina, Canada

Winsome Resources (ASX:WR1) has discovered a new pegmatite dyke through recent fieldwork at its Adina project…